Alisol F
Cat. No.：YN251541
CAS No. ：155521-45-2
| 产品名称: | Alisol F |
| CAS No.: | 155521-45-2 |
| Chemical Name: | (8α,9β,11β,14β,16β,23S,24R)-16,23-epoxy-11,24,25-trihydroxy-dammar-13(17)-en-3-one |
| Synonyms: | 泽泻醇 F |
| 分子量: | 488.70 |
| 分子式: | C₃₀H₄₈O₅ |
| SMILES: | C[C@]1(C(C[C@@H]2O)=C([C@@H]3C)[C@](O[C@@]([C@@H](O)C(C)(O)C)([H])C3)([H])C1)[C@]([C@]2([H])[C@]4(CCC5=O)C)(CC[C@@]4([H])C5(C)C)C |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Alisol F 是从泽泻中分离得到的三萜，具有免疫抑制和抗病毒功能。Alisol F 在体外对乙肝病毒 (HBV) 表面抗原 (HBsAg) 的分泌具有抑制活性，其 IC50为 0.6 μM。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Bi, X., Wang, P., Ma, Q., et al.Anti-inflammatory activities and liver protection of alisol F and 25-anhydroalisol F through the inhibition of MAPK, STAT3, and NF-κB activation in vitro and in vivoMolecules22(6),951(2017)
Choi, E., Jang, E., and Lee, J.-H.Pharmacological activities of Alisma orientale against nonalcoholic fatty liver disease and metabolic syndrome: Literature reviewEvid. Based Complement. Alternat. Med.,2943162(2019)
